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Background: Metabolic abnormalities are usually linked with obesity; however, all obese people may not
be affected by this condition. It has been indicated that obese people with higher resting metabolic rate
(RMR) had an overall better metabolic proﬁle than observed in those with low RMR. This study aimed to
compare the RMR status of metabolically healthy (MHO) and unhealthy obese (MUHO).
Design: Cross-sectional sample of 226 obese women (BMI > 30 kg/m2) aged 17e69 years participated in
the study. Participants were classiﬁed as MHO and MUHO. Metabolic health status was deﬁned using
Karelis deﬁnition. Metabolic proﬁle, RMR, and body composition were examined.
Result: MHO participants showed more favorable lipid proﬁle, had reduced insulin resistance and lower
total fat percentage and fat mass. RMR per BMI was 25% higher in the MHO group compared to the
MUHO subjects. Interestingly by adding RMR/kg in the binary regression model for ﬁnding the modu-
latory role of RMR on the Karelis criteria, no signiﬁcant difference was observed anymore regarding the
Homeostasis Model Assessment (HOMA) between the MHO and MUHO participants.
Conclusion: In this study we did not observe any major effects of RMR on metabolic health criteria except
for the HOMA. Further studies are needed to investigate the effects of RMR on glucose abnormalities that
may lead to modify cardio-metabolic criteria.
© 2016 Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The prevalence of obesity has increased signiﬁcantly worldwide
during the past two decades, a trend that now continues to increase
at an alarming rate acrossmost age groups [1]. Currently, more than
one billion adults all over the world are overweight; in addition, at
least 300 million are suffering from clinical obesity [2]. However
metabolic abnormalities are usually linked with obesity, they do
not affect all obese people [3]. It has been indicated that approxi-
mately 10e25% of obese people [4] and a fraction of morbidly obese
subjects [5] are not affected by metabolic disturbances [6e8]. Two
subtypes of obesity have been identiﬁed in the literature [1,9]. Oney Nutrition, School of Nutri-
f Medical Sciences (TUMS),
i).
n open access article under the Csubset of individuals has been termed the metabolically healthy
obese (MHO) [10]. These “metabolically healthy but obese” in-
dividuals in spite of having large amounts of fat mass, have normal
blood pressure, a favorable lipid proﬁle, a lower proportion of
visceral fat, less liver fat and a normal glucose metabolism [11e13].
Emerging evidence suggests that this could be as a result of lower
visceral fat levels and earlier onset of obesity [8]. A second subset,
has been termed the metabolically unhealthy obese (MUHO), have
substantial risk factors for obesity-related disorders such as dia-
betes, metabolic syndrome, and cardiovascular disease, that could
be due to the higher fat mass and plasma triglycerides as well as
higher visceral fat and liver content [1,14,15].
Furthermore, it has been theoretically demonstrated that in-
dividuals with low RMR (Resting Metabolic Rate) are at increased
risk of developing obesity-related disorders, since a larger portion
of their daily food intake is stored as fat, even with the similar
calorie intake [12]. Earlier data [16] indicated that obese subjects
with higher RMR had an overall better metabolic proﬁle thanC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
B. Hosseini et al. / Journal of Nutrition & Intermediary Metabolism 6 (2016) 48e53 49observed in obese individuals with low RMR. Similarly, they had
lower fasting plasma glucose and 2- hour post-load glucose levels
than low RMR obese people [17]. In addition, they had a better lipid
proﬁle and lower CVD risk scores [16]. Recent studies adjust RMR
per kg bodyweight or to a less extent BMI to compare individuals of
various body sizes. Use of the ratio of RMR to body weight or BMI
implies that RMR is proportional to body weight or BMI and body
weight or BMI contribute in a constant fashion to RMR over the
wide range of body weight or BMI. The tendency of RMR to increase
more gradually as body weight rises was previously reported by
Schoﬁeld [18]. Moreover, Owen et al. [19] reviewed data demon-
strating that RMR per kg body weight decreases as body weight
increases. Accordingly, it has been reported that the best RMR per
kg body weight cut-off value in order to predict the risk of obesity
and obesity-related disorders is 20 kcal/24 h/kg [17].
There are limited studies that have evaluated the relationship
between RMR and the risk of developing obesity-related disorders,
and the ﬁndings from these studies are inconclusive [20e22]. The
aim of this study was to compare the RMR status in the MHO
compare to MUHO participants; and also, determine the effects of
RMR on Karelis metabolic health criteria.
2. Methods and materials
2.1. Study population
The study was conducted as a cross sectional on 226 obese fe-
male adults aged 17e69 years old who fulﬁlled the study criteria.
All women were recruited from a nutrition clinic of the Shariati
Hospital’s outpatient clinic. The registered individuals in the clinic
were enrolled in our study based on the inclusion and exclusion
criteria. Therefore, each obese woman registered in the nutrition
clinic who met the entrance requirements for study enrolment was
invited to participate in this study. Patients were selected according
to our deﬁned inclusion criteria, which were having a BMI > 30 kg/
m2, absence of any acute or chronic inﬂammatory state, no history
of hypertension, no alcohol or drug abuse, and not being pregnant.
Accordingly, women who had a history of any condition affecting
inﬂammatory markers such as known cardiovascular disease, thy-
roid diseases, malignancies, current smoking, diabetes mellitus,
sustained hypertension, heart failure, acute or chronic infections,
and hepatic or renal diseases were excluded from the study. All
participants provided written and informed consent forms
(approved by TUMS Ethics Committee, with the following identi-
ﬁcation: 94-01-161-28473). Participants were asked to maintain
their usual diet and avoid doing vigorous exercise for 2 days prior to
the study. The study was conducted by the School of Nutritional
Sciences and Dietetics, Tehran University of Medical Sciences,
Tehran, Iran.
2.2. Determination of metabolic health status
Metabolic health status was deﬁned using aMH deﬁnition based
on Karelis cardio-metabolic abnormalities as presenting at least
four of the followings: TAG 150 mg/dl, HDL-C 50 mg/dl and no
treatment, LDL-C 100 mg/dl and no treatment, Total
cholesterol 201 mg/dl, and HOMA 1.95 [23]. In order to
compare the RMR status differences, participants generating the
following groups: MHO, and MUHO.
2.3. Determination of RMR/kg cut-off value
According to ROC analysis the best RMR/kg cut-off value in order
to predict the risk of obesity-related disorders was 20 kcal/24 h/kg
[17]. Hence, the women were categorized into two groups: RMR/kg  20 kcal/24 h/kg and RMR/kg < 20 kcal/24 h/kg. We also
measured RMR per BMI as a separate variable; however, due to the
lack of any cut-off point for this variable in the literature we could
not divide the participants according to it.
2.4. Biochemical assay
Serum was prepared from blood sample after having 10e12 h
fasting state from each subject. Serum samples were aliquot into
1 ml tubes and stored at 80 C.
All baseline blood samples were obtained between 8:00 and
10:00 a.m. Serum was centrifuged, aliquoted and stored at a tem-
perature of 80 C. All samples were analyzed by means of a single
assay. Glucose Oxidase Phenol 4-Aminoantipyrine Peroxidase
(GOD/PAP) method was used for the measurement of fasting serum
glucose, and, triglyceride levels were measured by Glycerol-3-
phosphate oxidase Phenol 4-Aminoantipyrine Peroxidase (GPO-
PAP) method. Total cholesterol levels were measured by Enzymatic
Endpoint method, and direct high and low density lipoprotein was
measured by enzymatic clearance assay. Fasting serum glucose and
lipid proﬁle measurements were done with the use of Randox
laboratories kit (Hitachi 902).
Fasting serum glucose (FBG), total, high density lipoprotein
(HDL) cholesterol, low density lipoprotein (LDL) cholesterol and
triglycerides levels were measured by the Endocrinology and
Metabolism Research Center laboratory of Shariatei hospital. Serum
glucose concentrations were determined using colorimetric
method based on glucose oxidase enzymes and 4-aminoantipyrine.
Serum lipids were analyzed by the enzymatic endpoint method,
and HDL cholesterol was measured by means of an enzymatic
clearance. Triglyceride levels were analyzed using the enzyme
glycerol phosphate oxidize. Serum hypersensitive C-reactive pro-
tein (hs-CRP), a pro-inﬂammatory biomarker, was determined us-
ing a high-sensitivity immunoturbidimetric assay (Hitachi 902
analyzer; Hitachi LTD, Tokyo, Japan). All inter-assay calculated co-
efﬁcients of variation were within the normal range of enzymatic
kits data sheets. Serum Hyper sensitivity C-reactive protein
(hsCRP), was assessed using a imonoturbidimetric assay (High
sensitivity assay, by Hitachi 902). Serum insulin concentrations
were analyzed through enzyme-linked immunosorbent assay
(ELISA) method (Human insulin ELISA kit, DRG Pharmaceuticals,
GmbH, Germany) minimum detectable concentrationwas 1.76 mlU/
ml, Intra CV was 2.19% and Inter CV was 4.4%.
2.5. RMR measurements
Professional nutritionists performed analysis on all recruited
subjects through a standard protocol that has been described in
detail previously [24]. RMR is the synonym of resting metabolic
rate. RMR was determined using Fitmate calorimetry (Cosmed
Company, Rome, Italy). Fitmate is a desktop device which is
designed to provide accurate RMR for all ﬁelds relating to obesity
and malnutrition with a mask to cover nose and mouth. The device
is designed to analyze oxygen consumption and energy expendi-
ture during both rest and exercise. A turbine ﬂowmeter is used to
measure ventilation and a galvanic fuel cell oxygen sensor for
measuring the proportion of oxygen in expiration gases. Further-
more, a patent-pending sampling method is used, which allows the
analyzer to monitor the performance of a metabolic cart in a
standard mixing chamber. RMR was calculated using data on
particularly oxygen consumption, a ﬁxed respiratory quotient of
0.85, and estimated quantity of urinary nitrogen using a modiﬁed
Weir equation.
Weir equation: RMR¼ (O2 consumed [liter]  3.941 þ produced
Co2 [liter]  1.11)  1440 min/d.
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overnight fasting. Participants were asked to be in a fasting state, to
remain in a resting state for 12 h before the test and also, to refrain
from smoking cigarettes for at least 1 h before the procedure
commencement; however, a 12-h fasting was regarded as the ideal
interval to ensure that the body was in a resting and post-
absorptive state. Patients were instructed to have a rest in the su-
pine position on a mattress for 15 min. Afterward, they were
measured (20-min procedure). The ﬁrst 5 min were not used, and
only the last 15 min were included to calculate RMR.
2.6. Complete body composition measurements
The researchers analyzes the body composition of all partici-
pants using BODY COMPOSITION ANALYZER BC- 418 MAdTanita
(UK) by strictly following the techniques, procedure and precaution
of the manufacturer’s protocol [25]. The device calculates body fat
percentage, fat mass, and fat free mass (FFM) as well as muscle
mass on the basis of data obtained through dual-energy X-ray ab-
sorptiometry (DXA) by bioelectrical impedance analysis (BIA).
2.7. Statistical analysis
A minimum total sample size of (n ¼ 200) in two tailed hy-
pothesis was calculated based on 80% power (b ¼ 0.2) setting a 5%
signiﬁcance level (a ¼ 0.05) and Cohen’s d effect size of 0.4 to
compare the RMR status in the MHO group in comparison with the
MUHO participants. All statistical analysis was performed using
SPSS Software (IBM Corp. Released 2013. IBM SPSS Statistics for
Windows, Version 22.0 Armonk, NY: IBM Corp.). The values were
calculated as mean ± standard deviation. The independent sample
t-test and analysis of variance were employed to compare the dif-
ferences between the means of variables. The chi-square test was
used to compare the frequency of variables between 2 groups. We
used the Binary regression models for investigating the RMR/kg
effect on the metabolic healthy status, in which RMR/kg was
considered as independent variable (covariate in the model) and
Karelis criteria were considered as dependent variables Statistical
signiﬁcance was set as P < 0.05 for all tests.
3. Results
Among all participants, 61 women (27%) were obese yet meta-
bolically healthy (MHO), while, 165 women (73%) were obese and
metabolically unhealthy (MUHO).
3.1. Anthropometric measures and clinical characteristics
Clinical and anthropometric characteristics of the study popu-
lation according to metabolic health status are presented in Table 1.
In comparison with their metabolically unhealthy counterparts,
MHO individuals had 18% lower fasting blood glucose. Similarly,
mean serum insulin in MHO was about one third of those suffering
from metabolically unhealthy state. Moreover, MHO subjects
showed more favorable lipid proﬁle, speciﬁcally they had respec-
tively 30%, 7% and 15% lower mean serum triglyceride, total
cholesterol and LDL-C; as well as 21% higher mean serum HDL-C
compared to MUHO participants. Similar ﬁnding was observed by
considering serum hsCRP. To illustrate, mean serum hsCRP in
MUHO subjects was about 70% higher compared to our MHO par-
ticipants. Furthermore, as far as the body composition is concerned,
our result demonstrated that there was statistically signiﬁcant
difference regarding fat percentage (P ¼ 0.0003), FM (P ¼ 0.005)
between two groups. In particular, MUHO subjects had respectively
6% and 8% higher total fat percentage and fat mass in comparisonwith MHO participants. However, there was no signiﬁcant differ-
ence in BMI, visceral fat, FFM, RMR and RMR per Kg body weight
among the two groups (P > 0.05). Although, it should be noted that
RMR per BMI was 25% higher in MHO compared to the MUHO
subjects (P ¼ 0.003).
3.2. Findings according to categorized RMR/kg
We try for ﬁnding the results from RMR/kg, so we divided the
participants into two groups based on the RMR/kg: RMR/kg lower
than 20 kcal/24 h/kg (n ¼ 113) and equal to or greater than 20 kcal/
24 h/kg (n ¼ 113). We found signiﬁcant differences by considering
the insulin (P ¼ 0.0001), total cholesterol (P ¼ 0. 003), LDL-C
(P < 0.0001), BMI (P ¼ < 0.0001), fat percentage (P ¼ 0.0001), FM
(P < 0.0001) and visceral fat (P < 0.0001) among two groups
(Table 2). In particular serum insulin as well as hs-CRP in partici-
pants with RMR/kg  20 kcal/24 h/kg were respectively 21% and
25% lower compared to those with RMR/kg < 20 kcal/24 h/kg.
Furthermore, as far as the body composition is concerned, total fat
percent, fat mass as well as visceral fat were respectively 5%, 10%
and 13% lower in participants with RMR/kg  20 kcal/24 h/kg in
comparison with women who had RMR/kg < 20 kcal/24 h/kg.
However, after controlling energy intake and age effect, only insulin
and visceral fat had respectively signiﬁcant and marginally signif-
icant differences between two groups (P ¼ 0.001, P ¼ 0.06) (see
Table 3).
3.3. Mediator effects of RMR/kg on Karelis criteria
As it was mentioned above, we found signiﬁcant differences
regarding Karelis criteria between MHO and MUHO groups
(p < 0.05). However, after adding RMR/kg in the binary regression
model no signiﬁcant difference was observed anymore regarding
HOMA among the two groups (p > 0.05), whichmeans that RMR/kg
may have modulator effects on HOMA.
4. Discussion
In the present study, we hypothesized that RMR status would be
different in the healthy metabolically obese compare to the un-
healthy metabolically obese participants; which could have
modulator effects on Karelis metabolic health criteria regardless of
obesity status. Our hypothesis was only partly conﬁrmed.
Our study revealed that regards metabolic characteristics, the
MHO participants had lower fat mass, total fat percentage, reduced
insulin resistance, lower glucose concentrations, more favorable
lipid proﬁles and inﬂammatory state compared to themetabolically
unhealthy women. Interestingly, BMI, fat free mass as well as
visceral fat were not generally different between the MHO and the
metabolically unhealthy obese participants. Our ﬁndings is in line
with other studies reporting that MHO subjects had smaller waist
circumference, lower BMI, TAG, FPG and higher HDL-C concentra-
tions, reduced insulin resistance and were less hypertensive in
comparison with the MUHO participants [26]. The study also
demonstrated that no signiﬁcant difference was seen regarding
estimated body fat percentage among two groups. In accordance
with these ﬁndings, in another study 43 sedentary, obese, post-
menopausal women (50e70 yr old) were analyzed, and 17 of the 43
subjects were identiﬁed as beingMHO. The authors reported that in
spite of observing similar levels of total body fatness in MHO and at
risk obese postmenopausal women, MHO individuals showed 49%
less visceral adipose tissue compared to at risk subjects with the
metabolic syndrome. Moreover, MHO women showed a more
favorable lipid proﬁle, as evidenced by lower fasting triglycerides,
higher high density lipoprotein (HDL) cholesterol, lower fasting
Table 1
Baseline characteristics and anthropometric measurements of obese subjects according to MH criteria.
Variable MHO (n ¼ 61) mean ± SD MUHO (n ¼ 165) mean ± SD 95% CI of the difference P value
FBS (mg/dl) 89 ± 10.12 108.68 ± 39.73 9.52 to 29.83 0.0002
Insulin (mIU/L) 10.56 ± 5.23 33.63 ± 2.42 22.06 to 24.07 <0.0001
TG (mg/dl) 93.53 ± 29.89 130.78 ± 44.12 25.20 to 49.29 <0.0001
Total chol (mg/dl) 174.86 ± 37.49 187.65 ± 35.72 2.10 to 23.48 0.01
HDL-C (mg/dl) 57.4 ± 13.77 47.43 ± 9.67 13.19 to 6.74 <0.0001
LDL-C (mg/dl) 90.66 ± 22.02 105.12 ± 25.43 7.20 to 21.71 0.0001
Hs-CRP (mg/L) 1.94 ± 2.7 6.19 ± 7.21 2.38 to 6.11 <0.0001
BMI (kg/m2) 33.28 ± 2.56 33.63 ± 2.42 0.37 to 1.07 0.34
Fat % 39.92 ± 6.44 42.36 ± 3.44 1.12 to 3.75 0.0003
Fat mass (kg) 33.50 ± 8.15 36.23 ± 5.87 0.79 to 4.66 0.005
FFM (kg) 49.69 ± 5.54 49.05 ± 4.48 2.05 to 0.77 0.37
Visceral fat (kg) 9.00 ± 2.42 9.21 ± 2.01 0.41 to 0.83 0.51
RMR (Kcal/24 h) 1519.71 ± 330.38 1610.79 ± 316.05 3.39 to 185.56 0.058
RMR per Kg body weight 19.83 ± 1.92 19.63 ± 2.85 0.97 to 0.57 0.61
RMR per BMI 2.20 ± 1.13 1.75 ± 0.98 0.75 to 0.14 0.003
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sulin area under the curve after conducting an oral glucose toler-
ance test [27].
We did not ﬁnd any signiﬁcant difference regarding RMR and
RMR per kg body weight among two groups. However, RMR per
BMI was 25% higher in MHO subjects compared to their metabol-
ically unhealthy participants (P ¼ 0.003). No pervious study was
found regards investigating RMR per BMI differences in MHO and
MUHO participants; therefore, we could not compare our ﬁndings
with another data.
Based on the ﬁndings from several studies, a low RMR for a
given body composition has been identiﬁed as a risk factor for
weight gain and obesity [28]. However, the contribution of a low
RMR to the etiology of obesity is controversial [29]. Some studies
have reported that RMR has a strong genetic factor [30,31], and a
prospective study in Pima Indians demonstrated that RMR for a
given body composition, speciﬁcally RMR adjusted for fat-freemass
(FFM) and fat mass (FM), is a predictor of subsequent weight
change [32]. The authors reported that a relatively low RMR was
considered as a risk factor for body weight gain. After 4 y of follow-
up the risk of gaining 10 kg was about seven times greater in lowest
relatively RMR participants (lower tertile) compared to subjects
with the highest RMR (higher tertile). This ﬁnding is supported by
previous data [16] reported that obese people with higher RMR had
more favorable metabolic proﬁle compared to those with lower
RMR. Likewise, lower FPG, 2- hour post-load glucose levels, CVD
risk scores as well as better lipid proﬁle were observed in obese
participants with high RMR than low RMR obese people [16,17].
Although, a prospective study inwhites did not conﬁrm this ﬁndingTable 2
MH criteria of obese subjects according to categorized RMR/kg.
Variables RMR/kg < 20 (n ¼ 113) mean ± SD RMR/kg  20 (n ¼
FBS (mg/dl) 106.13 ± 43.62 101.76 ± 33.87
Insulin (mIU/L) 15.84 ± 6.23 12.67 ± 4.36
HOMA-IR 4.09 ± 4.06 3.85 ± 2.10
TG (mg/dl) 123.73 ± 31.7 121.42 ± 51.17
Total chol (mg/dl) 177.82 ± 32.05 190.80 ± 34.06
HDL-C (mg/dl) 49.43 ± 11.14 47.66 ± 7.57
LDL-C (mg/dl) 95.91 ± 23.48 109.42 ± 23.65
hs-CRP (mg/L) 5.96 ± 8.73 4.51 ± 4.6
BMI (kg/m2) 33.97 ± 2.94 32.63 ± 1.72
Fat % 42.73 ± 3.51 40.98 ± 3.12
Fat mass (kg) 37.4 ± 6.89 33.82 ± 4.63
FFM (kg) 49.71 ± 5.65 48.59 ± 3.69
Visceral fat (kg) 9.46 ± 2.15 8.31 ± 1.46
Adjusted for energy intake and age.[33].
Owen et al. reviewed demonstrating that RMR/kg body weight
decreases as body weight increases [34]. Furthermore, based on
ROC analysis the best RMR/kg cut-off value in order to predict the
risk of obesity was 20 kcal/24 h/kg [17]. Accordingly, participants
were categorized in to two groups. After adjusting energy intake
and age effect, only insulin and visceral fat had respectively sig-
niﬁcant and marginally signiﬁcant differences among two groups
(P ¼ 0.001, P ¼ 0.06). In particular serum insulin as well as visceral
fat in participants with RMR/kg 20 kcal/24 h/kg were respectively
21% and 13% lower compared to those with RMR/kg < 20 kcal/24 h/
kg. Similarly, Mirzaei et al. reported that participants with RMR/
kg < 20 kcal/24 h/kg showed considerably lower HDL levels, while,
serum levels of triglyceride and hs-CRP were higher in this group in
comparison with the participants who had RMR/kg  20 kcal/24 h/
kg [17].
Moreover, we found that RMR per Kg body weight may have
modulator effects on Karelis criteria particularly HOMA. When we
added RMR/kg in the model, interestingly we found that there was
no signiﬁcant difference regarding HOMA between MHO and
MUHO participants (p > 0.05). Although the exact mechanism
underlying the association between RMR and glucose metabolism
has not been clear yet, recent data has indicated that a central
pacemaker in the circadian system plays a role in controlling
glucose homeostasis and energy metabolism basically along with
each other [35]. Energy expenditure, which is tightly regulated by
circadian rhythm, has a key role in glucose metabolism [36].
Moreover, several studies have demonstrated that patients
suffering from insulin resistance have an increased resting113) mean ± SD 95% CI of the difference P value P value
14.60 to 5.86 0.40 0.75
4.22 to 1.40 0.0001 0.001
1.08 to 0.60 0.57 0.56
13.46 to 8.84 0.68 0.57
4.31 to 21.65 0.003 0.31
4.26 to 0.72 0.16 0.50
7.33 to 19.68 <0.0001 0.60
3.27 to 0.37 0.11 0.91
1.97 to 0.70 <0.0001 0.20
2.62 to 0.87 0.0001 0.65
5.11 to 2.04 <0.0001 0.22
2.37 to 0.13 0.07 0.23
1.63 to 0.66 <0.0001 0.06
Table 3
RMR per Kg body weight may modify the healthy metabolic criteria deﬁnition.
Karelis criteria Crude Model After added RMR per kg in the Model
B± S.E. 95% CI OR P value B± S.E. 95% CI OR P value
LDL 1.23 ± 0.53 0.101 to 0.836 0.29 0.02 1.12 ± 0.54 0.112 to 0.941 0.32 0.03
HDL 2.97 ± 1.19 1.848 to 204.366 19.59 0.01 2.99 ± 1.20 1.848 to 204.366 19.9 0.01
TG 2.95 ± 0.98 0.008 to 0.362 0.05 0.003 2.73 ± 0.97 0.010 to 0.438 0.06 0.005
hsCRP 0.34 ± 0.15 0.521 to 0.957 0.70 0.02 0.34 ± 0.15 0.522 to 0.968 0.71 0.03
HOMA 0.29 ± 0.13 0.570 to 0.968 0.74 0.02 0.23 ± 0.13 0.611 to 1.027 0.79 0.07
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sis (IIT) compared with those with normal glucose tolerance (NGT)
[37]. When and by which mechanisms these abnormalities occur
during the development of insulin resistance still remain unknown
[38]. Moreover, it has been indicated that in 560 Pima Indians,
sleeping metabolic rate was higher in both patients suffering from
diabetes and those with impaired glucose tolerance (IGT) in com-
parison with NGT subjects [38]. These ﬁndings demonstrate that
increases in RMR and decreases in IIT occur early in the develop-
ment of insulin resistance and type II diabetes, and that both
changes are linked with the progressive metabolic abnormalities
which occur during the development of the disease [37].
5. Conclusion
To conclude, our MHO participants had lower serum levels of
blood glucose, insulin, hsCRP, as well as fat percentage and fat mass,
and also, more favorable lipid proﬁle compared to the MUHO
group. It should be also noted that RMR per BMI was about 25%
greater in the MHO group compared to the MUHO group. After
adding RMR/kg in the binary regression model no signiﬁcant dif-
ference was found anymore regarding HOMA among the MHO and
MUHO groups (p > 0.05), which means that RMR/kg may have
modulator effects on HOMA. Furthermore, after dividing the par-
ticipants according to RMR/kg we found that those with the RMR/
kg > 20 had lower BMI, fat percentage, fat mass, and visceral fat
compared to those who had RMR/kg < 20. However, after adjusting
for energy intake and age, the difference was only statistically
signiﬁcant for insulin level.
To our knowledge no previous study compare the RMR differ-
ences between MHO and MUHO, and also our study provides the
ﬁrst data with respect to the modulator effects of RMR on Karelis
metabolic health criteria, in particular HOMA. A disadvantage of the
present cross-sectional study is that it does not allow deﬁnite
conclusions regarding cause and effect. RMR might affect Karelis
metabolic health criteria or vice versa. Future researches are war-
ranted to investigate the effects of RMR on glucose abnormalities,
which may led to modify cardio-metabolic criteria.
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